Orforglipron
Oral GLP-1 Agonist
Rosenstock J, Yabe D, Cox D et al.
Vafeidou K, Koufakis T, Stavropoulos K et al.
Tantoush M, Almaghrabi Y, Abusbaeh A et al.
This drug has been validated in the following preclinical models:
Alper A, Peleg G, Fagin A et al.
Kansakar U, Jankauskas SS, Pande S et al.